Byline: Will Doss
-
Celebrating Feinberg’s 2021 Residency Match
Fourth-year students celebrated their residency matches and reflected on their Feinberg experience during a socially distant Match Day.
-
Changes in Macrophages Drive Vulnerability to Lung Infections
An age-related accumulation of a signaling molecule may be one culprit behind older adults’ vulnerability to viral pneumonias, according to a recent study.
-
Feinberg Students Receive Fogarty Global Health Fellowships
Three Feinberg students have received Harvard-BU-Northwestern-University of New Mexico Fogarty Global Health Fellowships, supporting work in Botswana, South Africa and Tanzania.
-
Medical Student Investigates Gender Bias in Academic Publishing
Wadsworth Williams, a third-year medical student, has published two studies investigating the impact of gender bias in academic publishing.
-
DPT Student Expands his Horizons
Cole Graves, a third-year student in the Doctor of Physical Therapy (DPT) program, is interested in sports rehabilitation or neurological and vestibular therapy.
-
New Genetic Cause of Dystonia Revealed
Northwestern Medicine scientists discovered mutations in a scaffolding protein contributes to dystonia, an incurable movement disorder.
-
Cancer Drug May Have Potential for Pain Relief
Scientists discovered a previously unknown receptor site in a voltage-gated sodium channel, suggesting that a commonly-used cancer drug could be used to target this channel and relieve pain.
-
Blocking Cell Division in Glioblastoma
Blocking the arginine methylation pathway, which helps brain tumor cells proliferate by promoting cell division, could improve cancer therapies, according to a recent study.
-
Northwestern Investigators Explore COVID-19 Treatments
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
-
Tackling Inflammation to Improve Heart Attack Recovery
Inhibiting an inflammatory pathway reduced heart attack-induced damage in experimental models, according to a recent Northwestern Medicine study.
